UBS Group’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-101,391
| Closed | -$39K | – | 7602 |
|
|
2020
Q1 | $39K | Buy |
101,391
+77,385
| +322% | +$29.8K | ﹤0.01% | 5141 |
|
|
2019
Q4 | $10K | Buy |
24,006
+23,406
| +3,901% | +$9.75K | ﹤0.01% | 6241 |
|
|
2019
Q3 | $1K | Sell |
600
-409
| -41% | -$682 | ﹤0.01% | 6942 |
|
|
2019
Q2 | $2K | Buy |
1,009
+409
| +68% | +$811 | ﹤0.01% | 6794 |
|
|
2019
Q1 | $2K | Hold |
600
| – | – | ﹤0.01% | 6655 |
|
|
2018
Q4 | $1K | Sell |
600
-4,815
| -89% | -$8.03K | ﹤0.01% | 7015 |
|
|
2018
Q3 | $21K | Buy |
5,415
+4,815
| +803% | +$18.7K | ﹤0.01% | 5866 |
|
|
2018
Q2 | $2K | Hold |
600
| – | – | ﹤0.01% | 6835 |
|
|
2018
Q1 | $1K | Hold |
600
| – | – | ﹤0.01% | 6808 |
|
|
2017
Q4 | $1K | Sell |
600
-1,562
| -72% | -$2.6K | ﹤0.01% | 6779 |
|
|
2017
Q3 | $4K | Buy |
2,162
+1,562
| +260% | +$2.89K | ﹤0.01% | 6420 |
|
|
2017
Q2 | $3K | Buy |
600
+172
| +40% | +$860 | ﹤0.01% | 6371 |
|
|
2017
Q1 | $1K | Sell |
428
-2,552
| -86% | -$5.96K | ﹤0.01% | 6573 |
|
|
2016
Q4 | $8K | Buy |
+2,980
| New | +$8K | ﹤0.01% | 6086 |
|
|
2016
Q1 | – | Sell |
-2,709
| Closed | -$22K | – | 7000 |
|
|
2015
Q4 | $22K | Buy |
2,709
+1,848
| +215% | +$15K | ﹤0.01% | 5498 |
|
|
2015
Q3 | $7K | Sell |
861
-6,988
| -89% | -$56.8K | ﹤0.01% | 6132 |
|
|
2015
Q2 | $74K | Buy |
7,849
+3,606
| +85% | +$34K | ﹤0.01% | 4504 |
|
|
2015
Q1 | $39K | Buy |
4,243
+133
| +3% | +$1.22K | ﹤0.01% | 4856 |
|
|
2014
Q4 | $38K | Buy |
+4,110
| New | +$38K | ﹤0.01% | 4958 |
|